These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 15672452)
1. The impact of blood contamination on the proteome of cerebrospinal fluid. You JS; Gelfanova V; Knierman MD; Witzmann FA; Wang M; Hale JE Proteomics; 2005 Jan; 5(1):290-6. PubMed ID: 15672452 [TBL] [Abstract][Full Text] [Related]
5. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput. Macron C; Núñez Galindo A; Cominetti O; Dayon L Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411 [TBL] [Abstract][Full Text] [Related]
6. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification. Macron C; Lane L; Núñez Galindo A; Dayon L J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047 [TBL] [Abstract][Full Text] [Related]
7. Proteomics analysis of human cerebrospinal fluid. Yuan X; Desiderio DM J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808 [TBL] [Abstract][Full Text] [Related]
8. Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry. Davidsson P; Paulson L; Hesse C; Blennow K; Nilsson CL Proteomics; 2001 Mar; 1(3):444-52. PubMed ID: 11680889 [TBL] [Abstract][Full Text] [Related]
9. Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry. Davidsson P; Folkesson S; Christiansson M; Lindbjer M; Dellheden B; Blennow K; Westman-Brinkmalm A Rapid Commun Mass Spectrom; 2002; 16(22):2083-8. PubMed ID: 12415540 [TBL] [Abstract][Full Text] [Related]
10. Preliminary analysis of cerebrospinal fluid proteome in patients with neurocysticercosis. Tian XJ; Li JY; Huang Y; Xue YP Chin Med J (Engl); 2009 May; 122(9):1003-8. PubMed ID: 19493432 [TBL] [Abstract][Full Text] [Related]
11. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid. Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582 [TBL] [Abstract][Full Text] [Related]
12. Proteome studies of CSF in AD patients. Davidsson P; Sjögren M Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296 [TBL] [Abstract][Full Text] [Related]
13. Robust two-dimensional separation of intact proteins for bottom-up tandem mass spectrometry of the human CSF proteome. Bora A; Anderson C; Bachani M; Nath A; Cotter RJ J Proteome Res; 2012 Jun; 11(6):3143-9. PubMed ID: 22537003 [TBL] [Abstract][Full Text] [Related]
14. Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome. Aasebø E; Opsahl JA; Bjørlykke Y; Myhr KM; Kroksveen AC; Berven FS PLoS One; 2014; 9(3):e90429. PubMed ID: 24599184 [TBL] [Abstract][Full Text] [Related]
15. Mass spectrometric analysis of rat cerebrospinal fluid proteins following exposure to the neurotoxicant carbonyl sulfide. Lardinois O; Kirby PJ; Morgan DL; Sills RC; Tomer KB; Deterding LJ Rapid Commun Mass Spectrom; 2014 Dec; 28(23):2531-8. PubMed ID: 25366400 [TBL] [Abstract][Full Text] [Related]